PharmaSynth AS is now producing and commercializing N-desmethyl-AZ10419369, a new precursor for [11C]AZ10419369, a selective radioligand for 5-HT1B receptor, as well as its reference standard.
For more information regarding the ligand activity and findings, please consult the publication
A PET study with [11C]AZ10419369 to determine brain 5-HT1B receptor occupancy of zolmitriptan in healthy male volunteers
Varnäs K, Jucaite A, McCarthy DJ, Stenkrona P, Nord M, Halldin C, Farde L, Kanes S.
Cephalalgia. 2013 Jul;33(10):853-60